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Abstract. Immunoglobulin heavy chain binding pro-
tein (BiP, GRP 78) coprecipitates with soluble and
membrane-associated variants of the T-cell antigen
receptor a chain (TCR-a) which are stably retained
within the ER. Chelation of Caz+ during solubilization
of cells leads to the dissociation of BiP from the
TCR-a variants, which is dependent upon the avail-
ability of Mgz+ and hydrolyzable ATP; this suggests
that Call levels can serve to modulate the associa-
tion/dissociation of these proteins with BiP. In vivo
treatment of cells expressing either the soluble or
membrane-anchored TCR-a variants with the Ca2+
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insertion into or across the membrane of the ER
is only the first step in a long pathway leading to the
secretion of soluble proteins or the delivery of mem
brane proteins to the cell surface. Whether or not a protein
will reach its intended destination depends upon its struc-
tural maturation within the ER. The process of structural
maturation involves the folding of monomeric proteins as
well as the assembly of oligomeric complexes (Hurtley and
Helenius, 1989; Rose and Doms, 1988). Incompletematura-
tion often results in the failure to be transported through the
secretory system, whereby immature proteins are either
stably retained in the ER (Copeland et al., 1986; Kozutsumi
et al., 1988; Hurtley et al ., 1989) or are targeted for ER
degradation (Lippincott-Schwartz, et al., 1988; Chen et al .,
1988; Bonifacino et al ., 1989).
Retention is most likely accomplished by the interaction
of proteins with resident components of the ER. Currently,
the best candidate for such a retention molecule is the Ig
heavy chain binding protein, BiP (Haas and Wabl, 1983).
For BiP to serve successfully as a retention molecule for im-
mature or abnormal proteins it must be capable of recogniz-
ing either a determinant present in a wide variety ofproteins,
or, a variety of structural determinants. Just what structural
features determine binding to BiP is unknown. Although it
has been suggested that BiP might recognize exposed hydro-
phobic faces of denatured proteins (Pelham, 1986), recent
evidence has shown that a variety of short hydrophilic pep-
tides can bind to BiP with a wide range of affinities (Flynn
et al ., 1989).
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ionophore, A23187, or an inhibitor of an ER Caz+-
ATPase, thapsigargin, or the membrane-permeant Ca2+
chelator BAPTA-AM, results in the redistribution of
these proteins out of the ER and their subsequent
secretion or cell surface expression. Under the same
assay conditions, no movement of BiP out of the ER is
observed. Taken together, these observations indicate
that decreased Ca2+ levels result in the dissociation of
a protein bound to BiP, leading to its release from ER
retention. These data suggest that the intracellular fate
of newly synthesized proteins stably associated with
BiP can be regulated by Caz+ levels in the ER.
The presence of a retention molecule in such great abun-
dance as BiP, presents a dilemma regarding the maturation
of newly synthesized proteins. All newly synthesized pro-
teins are structurally immature and, as such, could be ex-
pected to interact with retention molecules. If this binding
were too stable, these proteins would be prevented from
folding or assembling and remain trapped within the ER. In-
deed, the transient interaction of some newly synthesized
proteins with BiP has been documented (Bole et al., 1986;
Gething et al., 1986; Domer et al ., 1987; Ng et al ., 1989;
Machamer et al ., 1990; Hendershot, 1990). Thus, as impor-
tant as it is to understand how proteins associate with BiP,
we must also understand how proteins are released from it.
The first insight into resolving this problem came with the
recognition that BiP is an ATP-binding protein (Lewis and
Pelham, 1985 ; Chappell et al., 1986), and is, moreover, an
ATPase; hydrolysis of ATP bound to BiP can result in the re-
lease of associated protein or peptide (Munro and Pelham,
1986; Kassenbrock and Kelly, 1989; Flynn et al ., 1989).
Thus, it is likely that the interaction with retention molecules
in the ER is a dynamic process ofbinding and release. When
aprotein is released it can progress in its maturation, and this
changes the probability of rebinding to abundant retention
molecules. One can envision that this cycle repeats itself un-
til the protein attains a configuration in which determinants
that interact with BiP are either lost or masked.
There is much that we do not know about the associa-
tion/dissociation cycle ofa protein with BiP Issues concern-
ing the physiological role of ATP in this process and whether
189there are special properties of the ER environment that might
influencethese interactions remains to be established. In this
study, we have utilized variants ofthe T-cellantigen receptor
a chain (TCR-a),' which are retained within the ER and
tightly bound to BiP in order to explore the relationship be-
tween intracellular fate and BiP association/dissociation. In
this report, two fundamental questions have been addressed:
(a) is the association with BiP responsible for selectively
trapping the TCR-a variants within the ER? and (b) can this
interaction be modulated in vivo such that ER retention is
converted to secretion or surface expression? Our findings
have allowed us to identify intralumenal Call as a factor in-
volved in potentially regulating the binding and release of
proteins from BiP within the ER, and, consequently, their
fate within the secretory pathway. We provide evidence that
the reduction of Cal+ levels in vitro as well as in vivo can
influence the release of a proteins from BiP . In intact cells
this manipulation is sufficient to cause the secretion or sur-
face expression ofproteins that are otherwise retained within
the ER. This conversion from retention to secretion takes
place in the absence of any breakdown ofthe ER or secretion
of BiP . High levels of Call in the ER may enhance the bind-
ing of newly synthesized proteins to BiP, whereas a drop
in lumenal Cal+ would provide a mechanism to enhance the
release of such proteins. Thus, variance in Cal+ levels within
the ER and associated compartments couldallowfor the spa-




ATP and adenylyl-imidodiphosphate (AMP-PNP) were purchased from
Boehringer-Mannheim Biochemicals (Indianapolis, IN). A23187, apyrase,
cycloheximide (CHX), EDTA, and EGTA were obtained from Sigma
Chemical Co. (St. Louis, MO). Ammonium chloride was supplied by Al-
drich Chemical Co. (Milwaukee, WI). BAPTA-AM was purchased from
Molecular Probes, Inc. (Eugene, OR). Thapsigargin was a kind gift from
Dr. M.R. Hanley (MRC, Cambridge, England) .
Antibodies
The following antibodies were used for immunoprecipitation and/or im-
munofluorescence studies: themurine IgG2AmAb A2B4-2 (A2B4), recog-
nizing a clonotypic determinant ofthe 2B4-a chain (Samelson et al., 1983);
the rat anti-BiP (IgG,c) mAb (Bole et al., 1986) which was a most generous
gift from Dr. D.G. Bole (University of Michigan, Ann Arbor, MI) and Dr.
L.M. Hendershot (St. Jude'sChildren's Research Hospital, Memphis, TN);
the murine mAb 7G7/B6 against an epitope localized to the extracellular
domain of the IL-2 receptor a chain (Rubin et al., 1985) provided by Dr.
D. L. Nelson (National Institutes of Health, Bethesda, MD), and a poly-
clonal rabbit antiserum recognizing ER resident proteins (Louvard et al.,
1982), kindly providedby Dr. D. Louvard (Pasteur Institute, Paris, France).
Stably TransfectedCHO Cells Expressing
aLipid-Linked Form ofTCR-ca
Stable CHO transfectants expressing a lipid-linked form of the TCR-a
subunit were produced as has been described previously by Lin et al.
(1990). Briefly, thecDNA encoding the extracellular domainofTCR-a end-
ing with the codon for Thr207, was fused in frame 5' to a 37 amino acid se-
quence of decay acceleration factor (DAF) which signals for the addition
of a glycosylphosphatidylinositol anchor (TCR-aGP0. The extracellular
1 Abbreviation used in thispaper: TCR-a, Tcell antigen receptor a chain.
The Journal of Cell Biology, Volume 114, 1991
domain of TCR-a in this membrane associated form is identical to that
found in the truncated soluble form, TCR-a, (see below). Throughout this
study, we have used a variant ofthis stably transfected cell line which ex-
presses lower levels of TCR-aGP, as compared with that described by Lin
et al. (1990); the steady state distribution of this protein localizes tothe ER.
TransientExpression ofaSoluble Truncated TCR-a
Chain in COSCells
COS cells from the American Type Culture Collection (Rockville, MD)
were transfected with the cDNA encoding a truncation of the clonotypic
T-cell receptor 2B4-a chain as has been previously described (Bonifacino
et al., 19906). Briefly, a translation stop codon was introduced after the
codon for Thr2°7 in the extracellular domain of the mature 2B4-(x protein
(TCR-ac) by using M13-based mutagenesis following the procedure of
Kunkel et al. (1987); the TCR-a, gene was cloned into an Xba I site present
in a modified version of the expression vector pCDM8 (Seed, 1987). (In
Figs. 2 and 6, COS cells were also transiently transfected with the expres-
sion vector pBJl-neo encoding the cDNA for a lipid-linked form of TCR-a
which has been previously described by Lin et al., 1990). COS fibroblast
cells grown to 70-80% confluency in 150-mm-diameter tissue culture
dishes were transfected with 1 ml calcium phosphate-precipitated DNA (20
,ug plasmid/ml), in 10 ml DME (Biofluids Inc., Rockville, MD) containing
10% FBS, 2 mM glutamine, and 0.15 mg/ml gentamicin (COS medium) as
indicated previously by Bonifacino et al. (1989) . After 16 h at 37°C, the




36 h after transfection, COS cells were preincubated for 15 min at 37°C
in methionine-free DME containing 5% FBS, 2 mM glutamine, and 0.15
mg/ml gentamicin. Cells were labeled for 30 min at 37°C with 0.25-0.5
MCi/ml [35S]methionine (Tran-35S-Label; ICN Radiochemicals, Irvine,
CA) in methionine-free medium, and chased in COS medium for the times
as indicated. Long-term labeling was performed using 1 mCi/ml [35S]me-
thioninein medium that was nine parts methionine-free RPMI 1640 and one
part methionine-containing RPMI 1640 (Biofluids Inc., Rockville, MD)
supplemented with 10% FBS, 2 mM glutamine, and 0.15 mg/ml gentami-
cin. Cells and supernatants were collected separately. Cell pellets were
solubilized in ice-cold lysis buffer containing 0.5 % (wt/vol) Triton X-100,
0.3 M NaCl, 50 mM Tris-Cl, pH 7.4, which included protease inhibitors
(Samelson et al ., 1985). Insoluble material was removed by centrifugation
for 15 min (or as indicated in figure legends), at maximum speed in a
microfuge (Beckman Instruments Inc., Palo Alto, CA) at 4°C. Specific pro-
teins were isolated from cell lysates or culture supernatants by immunopre-
cipitation using antibodies directed at the respective proteins coupled to
protein A-agarose (Bethesda Research Laboratories, Bethesda, MD) as de-
scribed (Samelson et al., 1985). Digestion with endo H was performed
by incubating immunoprecipitated proteins for 16 h at 37°C with 2.5 mU
endo H in 25 al buffer containing 0.1 M sodium phosphate buffer, pH 6.1,
0.1% Triton X-100, 0.03% SDS, and 20 mM EDTA. Samples were analyzed
by one-dimensional SDS-PAGE according to Samelson et al. (1985) or by
two-dimensional gel electrophoresis as described by O'Farrell et al. (1977).
Immunofluorescence Microscopy
The distribution of TCR-a variants and BiP was determined morphologi-
cally in COS cells transiently expressing TCR-a,, or in CHO cells stably
expressing a TCR-acre. Cells were grown to 50-60% confluency on 12-
mm round coverslips and fixed with 3% formaldehyde in PBS for 10 min
at room temperature. The cells were then permeabilized with 0.1% saponin
in PBS for 15 min at room temperature before the addition of antibody-
containing medium that contained 0.1% saponin (for these experiments ei-
ther an undiluted A2B4 culture supernatant or a 1:20 dilution of anti-BiP
culture supernatant or a 1:200 dilution ofanti-ER antiserum was used). Af-
ter incubation with the primary antibody, cells were washed in PBS with
0.1% BSA, and then incubated with the fluorescently labeled secondary an-
tibodyand washed again. Theantibodyincubations wereeach 1 hat temper-
ature. Coverslips were mounted in Fluoromount G (Southern Biotechnol-
ogy Associates, Birmingham, AL), and examined with an ICM405 inverted
microscope (Carl Zeiss Inc., Thornwood, NY).
190Figure 1 . Immunofluorescent colocalization of TCR-a, or1CRacp, and ER resident proteins . (A) 36 h after transfection, COS cells tran-
siently expressing TCR-a, were fixed with formaldehyde, permeabilized with saponin, and stained with an antibody recognizing the
TCR-a variant (A2B4) as well as an antiserum against ER proteins . (B)CHO cells stably expressing TCR-acp, were treated in the same
fashion . The steady state distribution ofTCR-a t and TCR-arP1 yields a reticular pattern of immunofluorescence throughout the cytoplasm
and distinct staining of the nuclear envelope which corresponds to that of the ER marker .
Intracellular Cat+Quantitation by
DigitalImaging Microscopy
Suzuki et al. Cat-dependent Association with BiP
￿
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1990) ; measurements were collected at 500nm after alternate excita
350 and 380 nm .
Cells were labeled for 1.5-2 h at 37°C with a loading solution containing
￿
Results 4mM Fura-2/W 0.07% DMSO, and 0.0145% F127 (a wetting solution
added to insure uniform distribution of Fura-2); 2mM probenecid was
added to increase the efficiency of Fura-21AM loading (Di Virigilio et al .,
￿
Variants ofthe T-Cell Receptor of ChainAre Stably
1990). Intracellular Cat* levels were quantitated using a Gould FD5000
￿
Retained within theER andAssociated WaltBiP
image processor (Fremount, CA) with software modified from RogerY .
Tsien (University ofCalifornia at San Diego, CA) (Tsien and Harootunian,
￿
Over the past several years, we have utilized the multimericTCR to explore the relationship between the fates of newly
synthesized proteins and their assembly into mature oligo-
meric complexes (Klausner et al ., 1990). The TCR is a
multi-subunitcomplex, which in most Tcells is constituted
by at least seven transmembrane proteins. The clonotypic a
andß subunits form adisulfide-linked heterodimer recogniz-
ingantigenin association with either class I or classII major
histocompatibility molecules. The TCRaß heterodimer is
noncovalently associated with the invariant subunits CD3-S,
--y, and -e, complexed with the ~2 homodimer. The murine
2B4 TCR-a chain, which is used in the studyreported here,
is synthesized as an tiM 38,000 precursor that is posttrans-
lationally modified into an M 42,000-44,000 form in the
Golgi system . We have recently shown that the full-length a
subunit of the receptor contains a determinant within its
transmembrane domain that targets the protein for retention
and rapid degradation in the ER. Interestingly, removal of
the transmembrane and cytoplasmic domains of TCRa re-
sults in a soluble, truncated variant, TCR-a,, which is not
secreted from thecell butretained within theER (Bonifacino
et al ., 1990a,b) . We wondered ifthe retentionofthis protein
was a consequence of its disposition as a soluble protein
within the ER lumen. We tested a membrane-associated
form of TCR-a in which the extracellular domain, although
identical to that in TCR-a,, is linked to the ER membrane
by a glycosylphoshatidylinositol anchor (TCR-aGPI, Lin et
al ., 1990). As shown in Fig. 1, A and B, the steady state
distribution of TCR-a, and TCR-aGPI, respectively, corre-
sponded to the ER, as assessed by double-labeling immu-
nofluorescence of the soluble- or lipid-linked variant andan
ER marker. TCRaGP, stably expressed in CHO cells, like
TCR-a,, revealed a reticular patternof fluorescence in addi-
tion to staining ofthe nuclear envelope coinciding with that
of the ER marker.
Pulse-chase experiments revealed that thevast majority of
TCR-a, andTCR-aGP, was retained intracellularlyas an endo
H-sensitive form (Fig. 2), suggesting that neither had
reached the medial Golgi cisternae, where carbohydrate
modificationsconferring endo H resistance occur (Tarentino
and Maley, 1974). This is in marked contrast to the full-
length TCR-a whichis rapidly degraded within the ER with
ahalf-life of 30-60 min (Bonifacino et al., 1989). Immuno-
precipitation ofthe culturesupernatant showed that 10-20%
of TCR-a, was released from the cells over 8 h as an endo
H-resistant protein, with <1% of TCRaGP, shed into the
medium.
In view of our interest in understanding the ER retention
of TCR-a, and TCRaGP,, we were particularly struck by the
coprecipitation ofa78-kD protein with thetwo TCRa vari-
ants (Fig. 2). This protein was specifically coprecipitated
with TCR-a, and TCR-aGPI isolated from cell lysates, but
not with the fraction found in culture supernatants (Fig. 2).
Identification of this protein as the immunoglobulin heavy
chain binding protein, BiP, wasaccomplished by examining
its migration on 2-D gels. Cells were labeled for 16 h with
[3IS]methionine and lysates immunoprecipitated with mAbs
recognizing TCR-a,, which migrates at -40 kD, (Fig. 3,
toppanel) and TCR-aGPI, at -43 kD (Fig. 3, middlepanel)
or BiP (Fig. 3, bottom panel) (Bole et al., 1986). BiP (Fig.
3, arrows), migrated as an acidic protein to a pH of N4 in
the first dimension of the nonequilibrium pH gradient elec-
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trophoresis (NEPHGE), and with a molecularmass of 78 kD
in the second dimension SDS-PAGE. Immunoprecipitation
of COS or CHO lysateswith an irrelevant antibody directed
against the 2B4 TCRß chain, revealed that the 78-kD spot
was specifically recognized by theanti-BiP antibody, where-
as the minor spots migrating adjacent to BiP were nonspe-
cific. Superimposition of autoradiograms and alignment of
the origins and nonspecific spots showed that the overall mi-
gration of BiP coprecipitated with TCR-al and TCR-aGPI
was the same. In these experiments we did notobserve co-
precipitation of either TCR-a mutant with the anti-BiP anti-
body (represented in Fig. 3, bottom panel), most likely due
to the fact that a small fraction of the cell lysate (1/100) was
used forimmunoprecipitation in orderto insure that theanti-
body was saturating.
If retention of TCRa, and TCRaGP, is a consequence of
their stable interaction with BiP, it would require that the
majority of allretained moleculesbe boundto BiP Densito-
metric scanning of the 2-D gels (Fig. 3, top and bottom
panel) indicatedthat theratio of TCR-avariants and copre-
cipitated BiP after 16 h of labeling was on the order of 4:1.
However, in order to accurately quantitate the fractional
labeling of the total protein populations, the relative half-
lives of these two proteins must be considered. We have ex-
perimentally determined that the half-lives of TCR-a, in
COS cells and TCR-aGPI in COS or CHO cells are -14 and
8 h, respectively, whereas that of BiP is >50 h in both cell
lines (data notshown). By taking into accountthe measured
intensities of the labeled proteins corrected for the number
of methionines in TCR-a, or TCR-aGPI, and BiP (four and
nine, respectively) (Saito et al., 1984; Becker et al., 1985;
Munro and Pelham, 1986), in addition to the relative half-
lives of these proteins, the calculated ratio of TCR-a, or
TCR-aGPI to BiP at steady state is N1:1 to 2:1. Thus, ER re-
tention of TCR-a, and TCRaGP, could be accounted for by
their stoichiometric interaction with BiP Throughout this
study, labeling periods of 4 h or less were used resulting in
a higher ratio of labeled a chain variant to BiP
ChelationofCat+ In Trtro ResultsinDissociation
of71CR-a Variants fromBiP
To examinethe nature of theinteraction between solubleand
lipid-linked forms of TCR-a and BiP, we used various bio-
chemical manipulations in an attempt to disrupt this stable
association in whole cell lysates. Cells expressing TCR-a,
were pulselabeledand solubilized in thepresence of various
reagents, and labeled TCR-a, was isolated by immunopre-
cipitation. ATP has been shown to cause the release of BiP
from associated proteins such as immunoglobulin heavy
chain (Munro and Pelham, 1986), while apyrase, aphospho-
diesterase, depletes levels of ATP, andstabilizes BiP binding
(Kassenbrock et al., 1988). SincetheER is knownto seques-
ter Call, we wondered whether Cal+ availability could in-
fluence the amount of BiP coprecipitated with TCR-c«, or
TCR-aGPI, thus, we compared the effect of EGTA which
chelates Cal+, to that of ATPand apyrase. (Fig. 4. top shows
the immunoprecipitation of TCR-a, from untreatedor treated
lysates. Fig. 4 bottom is a densitometric analysis of the rela-
tive ratio of BiP to the truncated a chain from the corre-
sponding gel lanes, where the ratio in untreated samples is
taken to be 100% .)
192Figure 2 . Stable retention of TCR-a, and TCR-aGPi in apre-Golgi compartment as evidencedby endo-H sensitivity. COS cells transiently
expressing TCR-a, (top panel) or TCR-aGP , (bottom panel) were pulse labeled 36 h after transfection, for 30 min with [35S]methionine
(0.25 mCi/ml) in methionine-freemedium at 37°C, andchased in the presence ofmethionine-containingmedium for the times as indicated .
Cell pellets were solubilized in 0.5% Triton X-100, and TCR-a variants were isolated from whole cell lysates or culture supernatants
by immunoprecipitation with a mAb (A2B4) bound to protein A-agarose . Immunoprecipitates were either untreated (-) or treated (+)
with endo H before analysis by SDS-PAGE on 13% acrylamide gels under reducing conditions . The vast majority of both TCR-a, and
TCR-aGP, (80%) remain stable intracellularly throughout the chase as an endo H-sensitive form with a minor fraction of TCR-a, (10%)
secreted into the culturemedium . Note the coprecipitation of a 78-kD protein with theTCR-amutants isolated from the cell lysate, though
not from the culture supernatants .
Solubilization in the presence ofATP (1 mM) resulted in
a 70-80% decrease in the recovery of BiP coprecipitated
with TCR-a, as compared to control, while the presence of
apyrase (100 U) during cell lysis stabilized the association
of BiP with TCR-a, (Fig . 4) . Interestingly, we have found
that the chelation of Cal+ by EGTA (5 mM) during cell ly-
sis, can result in a 70-80% decrease in the amount of BiP
coprecipitated with TCR-at . This effect can be blocked by
the addition of excess Cal+ (10 mM) to EGTA-treated ly-
sates (data not shown) . Pretreatment of cell lysates with
Suzuki et al . Ca'-dependent Association with BiP
apyrase (5 min at 4°C) blocked the EGTA-induced release
ofBiP (Fig. 4, API'RASE -" EGTA), suggesting that this ef-
fect is dependent upon the availability ofATP As apositive
control, we show that dissociation of BiP can be demon-
strated in untreated lysates (incubated for 5 min at 4°C), to
which EGTA hasbeen added(Fig . 4, NONE-EGTA) . Fur-
thermore, preincubation of cell lysates with AMP-PNP, a
nonhydrolyzable analogue of ATP, abrogates BiP release by
EGTA (Fig. 5 A, AMP-PNP- EGTA) .
While theaddition ofEGTA resulted in the releaseof BiP
193Figure 3. Migration of a 78-
kD protein coprecipitated with
TCR-a and TCR-aGPI is iden-
tical to that of BiP on two-
dimensional gel electrophore-
sis. Transiently uansfected COS
cells expressing TCR-a, (top
panel) or CHO cells express-
ing TCR-acrc (middle panel),
were labeled for 16 h at 37°C
with FS]methionine (0.5 mCl/
ml) in medium that was nine
parts methionine-free and one
part complete medium con-
taining unlabeled methionine ;
10% FBSwas included in the
labeling medium . Cell pellets
were extracted in0.5% Triton
X-100 and TCR-a, or BiP iso-
lated from whole cell lysates
by immunoprecipitation with
the mAbs A2B4 and anti-BiP
respectively (top and bottom
panel, respectively), from COS
cells, whereas TCR-aGPC was
isolated in the middle panel
from CHO cells . Immuno-
precipitates were analyzed by
NEPHGE using ampholytes
(pH, 3-10) in the first dimen-
sion, and then analyzed by
SDS-PAGE in the second di-
mension on 13% acrylamide
gels under reducing condi-
tions . The arrows indicate BiP
in each of the panels . Immu-
noprecipitation of COS or
CHO cell lysates with an ir-
relevant antibody reveals that
the 78-kD spot is specific to
the anti-BiP antibody, whereas
the minor spots adjacent to BiP
are nonspecific. Superimposi-
tion of autoradiograms align-
ing the origins and nonspe-
cific spots show that the BiP
coprecipitated with TCR-a,
and TCR-aop, are identical .
Figure 4. Chelation of Caz* in whole cell lysates results in the dissociation of BiP from TCR-a, . Transiently transfected COS cells ex-
pressing TCR-a, were pulse-labeled for 4 h with [35S]methionine (0.25 mCilml) in methionine-free medium at 37°C. Cell pellets were
solubilized in freshly prepared lysis buffer (0.5% Triton X-100) without additions, or with addition of eitherATP (1 mM, pH 7.6), apyrase
(200 Ulml), or EGTA (10mM, pH 7.6), and incubated for 10 min on ice . Pretreatment of lysates with apyrase for 5 min on ice was fol-
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194lowed by the addition ofEGTA (APYRASE -+EGTA), and incubated foran additional 10 min on ice; untreated lysates were held for 5 min
on ice after which EGTA was added and incubated for an additional 10 min as indicated by NONE - EGTA, serving as a positive
control. The detergent-insoluble material was pelleted by centrifugation for 15 min at4°C . TCR-a, proteins were isolated from whole cell
lysates by immunoprecipitation with A2B4 bound to protein A-agarose and analyzed by SDS-PAGE on 13% acrylamide gels .
Suzuki et al . C42'-dependent Association with BiP
￿
195Figure 5 . Release of BiP from TCR-a, in whole cell lysates in de-
pendent upon the availability ofMg", hydrolyzable ATP, and Cat+
concentrations . COS cells transiently expressing TCR-a, were
pulse labeled with [ 35S]methionine for 4 h at 37°C, after which the
cells were harvested . (A) Cells were lysed in the absence (NONE)
or presence of EGTA (5 mM) or ATP (1 mM) and incubated for
10 min on ice. Pretreatment of cell lysates withAMP-PNP (1 mM)
for 5 min on ice was followed by the addition of 5 mM EGTA (AMP-
PNP --" EGTA) for an additional 10 min on ice. The requirement
for Mgt+ was examined by lysing the cells in the presence ofEDTA
(5 mM), incubating the lysates on ice for 5 min, followed by the ad-
dition of 5 mM EGTA (EDTA- EGTA) or 1 mM ATP (EDTA-
ATP) for an extended 10 min . Finally, cell lysates fromCHO cells
expressing TCR-"GP, were pretreated in the presence ofEDTA plus
an excess of Mgt+ (10 MM MgCl 2 ) for 5 min, followed by addition
of 1 mM ATP (EDTA + Mgt-1- ATP) . (B) Cells were lysed in the
presence of 1 mM ATP and added CaC12 at the concentrations indi-
cated (0, 1, 10, 100 IM), and incubated for 10 min on ice . The
detergent-insoluble material was pelletedby centrifugation for 5 min
at 4°C and TCR-a, was isolated from cell lysates by immunoprecip-
itationwith A21í4 bound toproteinA-agaroseandanalyzed by SDS-
PAGE on 13 % acrylamine gels under reducing conditions .
from TCR-a,, the addition ofEDTA had the opposite effect,
resulting in enhanced BiP association . Treatment of lysates
with EDTA (5 mM) prevented the dissociation of BiP due to
the subsequent addition ofEGTA (EDTA- EGTA), orATP
(EDTA-ATP) . This suggested that Mgt+ might be required
for the ATP-dependent release of BiP from TCR-a, . This
was directly tested by first adding EDTA in the presence of
excess Mg" (10 mM) before the addition of ATP to the ly-
sates . When this was done, the ATP-induced release of BiP
was reconstituted (Fig . 5 A, EDTA + Mgt'- ATP) . Taken
together, these data suggest that the ability of Cal+ chelation
to dissociate TCR-a-BiP complexes requires both Mgt+ and
the hydrolysis of ATP
We have ruled out the possibility that EGTA affects the re-
lease of BiP by merely mimicking the addition of ATP, for
example, by increasing ATP levels in cell lysates due to the
inhibition of ATPases. This was examined by measuring the
levels ofATP hydrolysis in control and untreated cell lysates
by addition of -y"P ATP and adsorption of nucleotide by ac-
tivated charcoal after various periods of incubation at 4°C .
We found that over a 30-min period, ATP hydrolysis was the
same in control and EGTA-treated samples (data not shown) .
We were able to detect an 80% release of BiP in lysates
treated with EGTA 15 min after solubilization and immuno-
precipitation combined (shorter periods were not practica-
ble), demonstrating that the dissociation effected by EGTA
was rapid .
While ATP appeared to be a requirement for the EGTA-
induced release of BiP in cell lysates, the reverse was also
true in that Cal+ acted to antagonize the ability of ATP to
dissociate BiP from TCR-a, (Fig . 5 B) . Titration of CaC12
in cell lysates containing 1mM ATP revealed that in the ab-
sence of added CaC12 in cell lysates, 20% of the BiP copre-
cipitated with TCR-a, was recovered relative to the control
samples not treated with CaC12 or ATP ; increasing concen-
trations of CaC12 to 100 p,M can antagonize the ATP-in-
duced release of BiP, such that 80% of coprecipitated BiP
remains associated with MR-a, . We have consistently found
that the effects of all these in vitro manipulations on the bind-
ing of BiP to the membrane-associated TCR-UGP, are indis-
tinguishable from those observed for the truncated form .
Releasefrom ER Retention in Intact Cells
Based on the observation that a reduction of Cal+ levels in
vitro could result in the release of MR-a, from BiP, we ex-
amined whether a correlate might be found in vivo. We
predicted that if Cal+ levels within the ER lumen could be
lowered sufficiently, the mutant TCR-a chains would dis-
sociate from BiP and escape from the ER, resulting in the
secretion of TCR-a, and the surface expression of TCR-
aaP, . To test this hypothesis, we initially used the Ca2+ iono-
phore, A23187, to lower ER Cat+ by allowing Call (and
Figure 6 . A23187-induced movement of TCR-a, and TCR-CYGP, out of the ER . COS cells transiently expressing TCR-a, (top panel) or
TCR-aGP, (middlepanel) were pulse labeled for 30 min with [ 35S]methionine in methionine-free medium and then incubated with medium
containing unlabeled methionine in the absence or presence ofA23187 (51M) at 37°C forthe times as indicated . Cell pellets were extracted
with 0.5% Triton X-100 and protein immunoprecipitated from whole cells lysates and supernatants with a mAb (A2)í4) recognizing the
TCR-a variant in the top and middle panels, or an anti-BiP antibody in the lower panel (BiP was isolated from cells expressing TCR-a,) .
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196Immunoprecipitates were either untreated (-)or treated (+) with endoH andanalyzed by SDS-PAGE on 13% acylamide gels under reduc-
ing conditions . Compare the intracellular fate of the TCR-a variants in untreated controls (Fig . 2) with that observed in A23187-treated
cells . The fate of BiP in untreated cells is identical to that seen in the presence of A23187.
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197Mgz+ to a lesser extent) to flow down its concentration gra-
dient into the cytosol (Reed, 1982) ; it has been inferred
that the majority of intracellular Caz+ is stored in the ER
(Gerok et al., 1990) and that intralumenal Caz+ levels are
The Journal of Cell Biology, Volume 114, 1991
Figure 7 . A23187 does not
alter the rate of The, secretion
in transiently transfected COS
cells . Cells were pulsed la-
beled with ['SS]methionine
for 30 min at 37°C, and then
chased in methionine-contain-
ing medium in the absence or
presence of A23187 (5 mM),
or A23187 with added CaCl2
(20 mM) . Tac, from cell ly-
sates and supernatants were
immunoprecipitated with the
mAb 7G7. Inununoprecipitates
were either untreated (-) or
treated (+) with endo H and
analyzed by SDS-PAGE on
13% acrylamide gels under
reducing conditions .
high with respect to cytosolic levels which range between 0.1
and 0.2 AM (Carafoli, 1987) . We found that cells pulse la-
beled and chased in the presence ofA23187 (5 uM) secreted
up to six times more TCRa, (Fig . 6, top panel) as com-
198Figure 8. Redistribution of 1CR-arp,, but not BiP, in cells treated with A23187. CHO cells stably expressing TCR-app, were incubated
with 50 mM NH4CI and 1 ug/ml cycloheximide in the absence or presence of A23187 (2.5 /M) for 3 h at 37°C and were prepared for
immunofluorescence as previously described (Lippincott-Schwartz et al ., 1990) . Briefly, cells were fixed in 3% formaldehyde in PBS, and
permeabilized in 0.1% saponin . Coverslips were incubated with either an antiTCR-a mAb A2B4 (A and C), recognizing TCR-acpt, or,
with an anti-BiPmAb (B andD), followed by fluorescently labeled secondary antibodies (rhodamine-conjugated goat antimouseand fluo-
rescein-labeled goat antirat) against the respective species isotypes . In the absence of ionophore, TCR-ciGp, and BiP (A and B, respec-
tively) are both distributed in a reticular network throughout the cytoplasm as well as staining of the nuclear envelope characteristic of
theER . After a3-h treatment with A23187, TCR-aGp j has redistributed to the cell surface (C), whereas BiP(D) appears indistinguishable
from controls with no loss in fluorescence intensity.
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199paredwith the untreated controls (Fig. 2, top panel) over an
8-h period. After 1 h in A23187, 5 % of MR-a, expressed
transiently in COS cells was present in the culture medium
as an endo H-resistant form, whereas in the control no
secreted protein was detectable. By 8 h 60% of labeled pro-
tein appeared in the culture supernatant in the presence of
ionophore, in contrast to only 10% in untreated cells. Exit
from the ER appeared to be the rate-limiting step in the
movement of this protein throughout the secretory pathway,
since all TCRa, immunoprecipitated from cell lysates was
endo H-sensitive. Some loss of total TCR«, was observed
in these experiments, most likely due to degradation. Like-
wise, COS cells expressing the membrane-associated TCR
aGPI were pulse labeled and chased in the presence of A23187
(5 juM). We observed the appearance of endo H-resistant
forms present intracellularly during the first hour (Fig. 6,
middle panel), running as a smear between the 70- and 49-
kD markers as well as at 43 kD. We believe that the increas-
ing amount of endo H-resistant material in the cell lysates
represents protein transported to the cell surface (refer to
Figs. 8 and 10). In contrast to untreated controls (Fig. 2, bot-
tompanel), ionophore treatment over an 8-h period resulted
in a continued loss ofendo H-sensitive TCRciGP, (N10% re-
maining), accompaniedbyacoordinate loss ofcoprecipitated
BiP similar to that observed with the truncated TCR-a. Ap-
proximately 20-30% of precipitable TCRaGP, is recovered
from the culture medium; the higher molecular weight form
isolated from the culture supernatant may result from the
clipping ofthe GPI anchor. A significant amount of TCR-aGP,
is degraded; whether this occurs at the surface or intracellu-
larly has not been established. However, we do know that
degradation in not likely to occurwithin the ER-Golgi system
since TCR-aGP, is stable in the presence of Cal+ perturbation
and brefeldin A, which redistributes Golgi membrane and
contents to the ER thereby preventing movement of protein
out of the ER (Lippincott-Schwartz, 1989) .
Notably, there is an absence of coprecipitated BiP with
TCR-a, and TCRaGP, isolated from the culture medium of
A23187-treated cells. We have found that ionophore treat-
ment does not yield secretion of newly synthesized BiP, evi-
denced by directly immunoprecipitating cell lysates and cul-
ture supernatants with the anti-BiP antibody (Fig. 6, bottom
panel). This is in marked contrast to a previous report by
Boothand Koch (1989) which indicated that A23187 induced
the secretion of various ER resident proteins including BiP
Furthermore, immunoblotting of cell lysates and superna-
tants from cells treated with A23187 for 4-8 h revealed that
the entire population of BiP remains intracellular in CHO or
COS cells expressing the TCRct variants (data not shown).
Thus, A23187 treatment causes intracellular dissociation of
TCR-a variants from BiP.
One explanation for the enhanced secretion of TCRa,
and surface expression of TCR-aGP, might be the accelerated
movement of all proteins throughout the secretory pathway
in response to Cal+ ionophore. To address this issue, we
have examined the effect of A23187 on a normally secreted
protein, utilizing a truncated soluble form of the humanIL-2
receptor a chain (Tac,; Bonifacino et al., 1990b) which is
efficiently secreted with a half-time of 1 h when expressed
transiently in COS cells (Fig. 7). The addition ofA23187 did
not alterthe rate oftransport ofthis protein through the secre-
tory pathway, although the ability to fully process secreted
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protein to an endo H-resistant form was somewhat impaired.
However, treatment of cells with A23187 in the presence of
added CaC12 (20 mM) permitted complete processing to
occur. These results suggest that the secretion of TCR-a, is
not simply a manifestation of a generalized increase in the
rate of protein transport through the secretory pathway.
TCR-uGp,, but Not BiP, Redistributes out ofthe ER
in Response to Cal+ ionophore
Although pulse-chase experiments indicated that TCR-a, and
TCRaGP, were moving through the secretory pathway in re-
sponse to ionophore while BiP was retained intracellu-
larly, we wondered whether these events occurred in cells
where the ER was morphologically and functionally intact.
By immunofluorescence microscopy we examined the distri-
bution of BiP in CHO cells expressing TCR-aGP, in the ab-
sence and presence of A23187 (5 IM, 3 h, 37°C) . Use of
the lipid-linked TCR-a variant rather than the soluble form
for these morphological studies, permitted visualization of
"secreted" protein as delivery to the cell surface. Control as
well as ionophore-treated cells were incubated with cyclo-
heximide (CHX, 1 pg/ml) to inhibit protein synthesis,
thereby allowing us to follow the movement of protein over
time, in addition to ammonium chloride (NH,CI, 50 mM),
which inhibits degradative enzymes within lysosomes poten-
tially allowing us to visualize redistribution of protein to
these structures. In untreated control cells, TCR-aGP, and
BiP (Fig. 8, A and B, respectively), are distributed in a retic-
ular and punctate pattern characteristic of the ER, with evi-
dent staining of the nuclear envelope. After a 3-h treatment
with A23187, the distribution of TCR-aGP, (Fig. 8 C)
showed a dramatic shiftto the plasma membrane. In marked
contrast, the distribution of BiP after the same treatment,
was indistinguishable from its ER localization in control
cells. By this qualitative analysis, no disruption of ER struc-
ture was detected. Furthermore, double-labeling experi-
ments with antibodies recognizing TCR-a and a polyclonal
antisera directed against ER resident proteins (Louvard et
al., 1982), showed that TCR-aGP, traverses the secretory
pathway, while ER resident proteins remain localized to the
ER, with no apparent breakdown of ER structural integrity
in the presence of A23187 for 1, 2, or 4 h (data not shown) .
Although we cannot completelyassess the degree to which
the ER remains functionally intact given A23187 applica-
tion, we havereason to believe that ionophore treatment does
not dramatically disrupt ER function. For example, the se-
cretion rate of a soluble protein such as Tac, was not al-
tered by A23187 as was shown in Fig. 7. In addition, we have
found no change in the rate of ER degradation of the full-
length TCR-a chain upon perturbation with ionophore (data
not shown) .
TliR-ciGPl, but Not MR, Redistributes out ofthe ER
in Response to a Decline in Intralumenal Cat+ Levels
One primary concern in the application of Cal+ ionophores
is its lack of specificity and its undefined effects. To further
test that a decline in intralumenal ER Cal+ levels was re-
sponsible for the release of TCR-aGP, from BiP and its exit
from the ER, we used the tumor promoter thapsigargin (Tg;
Thastrup et al., 1989; Booth and Koch, 1989). Nanomolar

















































































































































































































































































































































































































































































































































































































































































.cifically an ER Cal+ ATPase, resulting in the reduction of
ER Cat+ levels and a concomitant increase of cytosolic Cal+
(Thastrup et al ., 1990) . CHO cells expressing TCRaGrl ,
were either untreated or treated with Tg (50 nM) for 0, 1, or
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Figure 10. Golgi processing
ofTCR-acri in Tg ; orBAPTA
AM-treated cells . CHO cells
stably expressing TCR-aGpi
were pulse labeled for30 min
with [35S]methionine in methi-
onine-free medium and then
incubated with medium con-
taining unlabeled methionme
in the absence (top panel)
or presence of Tg (100 nM,
middle panel) or BAPTAAM
(100 nM, bonom panel) .
TCRaon was isolated and
analyzed as described in
Fig . 6 .
3 h (Fig . 9) and the distribution of TCRaGPj and BiP was
examined by immunotluorescence microscopy. In untreated
controls, TCRacri, like BiP, localizes to the ER, yielding a
reticular networkthroughout the cytoplasm. After 1 h expo-sure to Tg, the GPI-linked TCR-a has apparently moved into
a Golgi-like distribution in at least 90°10 of the cells with re-
sidual reticular staining; by 3 h TCR-aGP, was overwhelm-
ingly on the cell surface. Double labeling of TCR-acpt and
the Golgi marker mannosidase II (man II) has shown that
TCRaGPI colocalizes with man II after 30-60 min in Tg. In
marked contrast, BiP remained localized to the ER when
cells were incubated with Tg (time = 1 and 3 h) indistin-
guishable from controls (time = 0 h). Furthermore, we have
foundthat Tg has no effect on the distribution of ER resident
proteins recognized by a polyclonal antisera described by
Louvard et al. (1982), indicating that structural proteins of
the ER inclusive of BiP are not released from this compart-
ment (data not shown).
Consistent with these morphological data we have found
that in pulse-chase experiments, movement through the Golgi
system can be detected in cells expressing TCR-Clop, that
have been chased for up to 6 h with Tg (50 nM) (Fig. 10).
After a 1-h chase period with Tg, two endo H-resistant
forms of TCR-Clop, are observed (Fig. 10, middle panel);
the highest molecular weight form most likely represents the
addition of sialic acid within the trans Golgi (Lippincott-
Schwartz et al ., 1988), while the lover molecular weight
endo H-resistant species represents processing of TCRClop,
in the medial Golgi. No endo H resistance of TCR-aGpt is
evident in the untreated controls (Fig. 10, top panel).
Finally, one critical possibility that is not addressed by the
experiments using A23187 and Tg, is whether the dissocia-
tion of soluble and lipid-linked TCR-a variants from BiP and
their transport out of the ER is due, not to the decline in lu-
menal ER Caz+, but rather to the increase of cytosolic Caz+
induced by both of these reagents. To distinguish between
these alternatives, we have used the membrane-permeant
Caz+ chelator BAPTA-AM . BAPTA is a derivative of EGTA
that specifically binds Caz+; when modified by an acetoxy-
methylester group (AM) it is rendered lipophilic and thus
able to cross the plasma membrane as well as intracellular
membranes, including that of the ER. Once within the cell,
cellular esterases cleave the AM group, whereby the mole-
cule is able to bind Caz+ and is no longer membrane per-
meant (Lew et al., 1982; Grynkiewicz et al., 1985) . We have
found that TCR-arpq in pulse-labeled CHO cells chased in
the presence of BAPTA-AM alone (100 nM), is transported
through the secretory pathway to theplasmamembrane (Fig.
10, bottom panel) . Within the first hour of exposure to
BAPTA-AM, Golgi-processed, endo H-resistant TCR-arp,
is apparent in contrast to the controls (Fig. 10, top panel) .
The posttranslational modifications of TCR-Clop, in addition
to the kinetics oftransport in response to BAPTA treatment,
are comparableto that observed with Tg. Common toA23187,
Tg, and BAPTAAM, decreasing amounts of BiP are copre-
cipitated in accord with decreasing amounts of unprocessed
TCR-aopt. To confirm that cytosolic-free Caz+ levels do not
increase in the presence ofBAPTA-AM, quantitation of free
Caz+ levels in control versus BAPTA-AM-treated cells was
performed using digital imaging microscopy (Tsien and
Harootunian, 1990; Mooreet al., 1990). CHO cellsexpress-
ing TCR-aGp, were loaded with FURA-2 (see Materials and
Methods), in the absence or presence of BAPTAAM (100
nM) and then treated with Tg (0.2 nM) to induce an increase
in cytosolic Caz+ levels. Results indicated that when Tg was
added to control cells, Caz+ levels increased from 170 nM
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to millimolar levels within 3 min, whereas in BAPTAtreated
cells, free Caz+ concentrations did not increase above basal
levels. These results support the interpretation that reducing
Caz+ levels within the ER and not increasing cytosolic Cat+,
leads to the dissociation ofER retained TCR-a variants from
BiP within this compartment, resulting in their release from
ER retention.
Discussion
Intrinsic to the maturationofnewly synthesized proteins des-
tined for secretion or expression on the plasma membrane,
are quality control mechanismsby which abnormal and im-
mature proteins are prevented from leaving the ER, either by
the retention or degradation of these proteins within this
compartment. The finding that two variants of the TCRa
chain (TCRa, and TCRaGp,) were retained stably within
the ER led us to explore the molecular basis underlyingthis
phenomenon. One possible explanation for the retention of
TCR-a, and TCR-Clop,, is that these molecules form insolu-
ble aggregates that impede their egress from the ER. How-
ever, when we examined this possibility by sucrose gradient
analysis, we found that TCRa,, as well as TCR-aGpt, exist
as monomers without formation of large aggregated com-
plexes (Suzuki, C., and R. Klausner, unpublished observa-
tions). Alternatively, retention might be mediated by a car-
boxyl-terminal determinant such as that described by Sitia
et al. (1990) who have shown that a free cysteine residue
within the COOH-terminus of the immunoglobulin A chain
is responsible for its retention within the ER system. The un-
paired cysteine residue involved in the disulfide linkage ofthe
TCRaß heterodimer (Cys2oz), which is maintained in both
TCRa, and TCRClop,, might function in a similar fashion;
however, mutation of Cyszo2 to a serine residue in TCR-a,
does not alter its fate as an ER-retained protein (Suzuki, C.,
and R. Klausner, unpublished observations). Moreover, ad-
dition of various carboxyl-terminal sequences (such as the
cytoplasmic tail of the IL-2 receptor a chain) to the same
extracellular sequences present in the truncated variant, re-
sults in proteins that are nevertheless trapped within the ER
(Suzuki, C., and R. Klausner, unpublished observations).
These findings suggest that a specific carboxyl-terminal se-
quence per se, is not responsible for retaining TCR-a, and
TCRClap, in the ER.
Coprecipitation of the abundant ER resident protein, BiP,
with both TCR-a, and TCR-aGp,, prompted us to question
whether ER retention of the TCR-a mutants was mediated
by BiP interaction. Previous workby Hendershotet al. (1987)
and Polloket al. (1987) has provided strong evidence that the
stable retention of newly synthesized Ig heavy chains within
the ER is a consequence oftheir association with BiR They
have shown that large deletions in either the first constant re-
gion domain (CHI) or in the variable region (VH) of Ig
heavy chains result in proteins that do not interact with BiP
The lack of BiP binding is correlated with secretion of CH,
mutants and the surface expression of VH mutants.
One focus ofour investigation has beento address whether
the association with BiP is responsible for the retention of
soluble and membrane-associated proteins, such as TCR-a,
and TCR-Clap,, respectively. Another aspect has been to ex-
amine whether the stable interaction of these ER-retained
proteins with BiP can be modulated in vivo, such that release
203from ER retention is coincident with release from BiP The
latter issue is of importance not only with respect to under-
standing ER retention, but also in view of several other pro-
posed functions ofBiP, which include the catalysis of protein
folding (Pelham, 1989a,b) and the assembly of oligomeric
complexes (Pelham, 1989a,b; Rothman, 1989). Identifying
the rules by which newly synthesized proteins are not only
bound to, but also released from BiP, is critical to examining
the role of BiP in normal protein maturation, assembly, and
transport within the ER.
Our examination of the in vitro effect of Cal+ availability
on the association of BiP and the TCR-a variants led us
to the finding that chelation of Cal+ in whole cell lysates
by EGTA results in the release of BiP from TCRa, and
TCRaopc, and that this process is dependent upon the avail-
ability ofMgz+ and hydrolyzable ATP Conversely, the addi-
tion ofCaz+ can stabilize the association of protein with BiP
by antagonizing its ATP-induced release. Kassenbrock and
Kelly (1989) have shown that for purified BiP, Caz+ can in-
hibit its ATPase activity such that 0.5 mM Caz+ reduces
ATP hydrolysis by 70 % . Our findings suggest that modulat-
ing the ATPase activity of BiP via Caz+ levels can serve to
regulate the binding to, and release of, proteins associated
with BiP . To what extent other proteins retained within the
ER exhibit such Caz+-dependent binding to BiP remains
to be examined. Preliminary results (Letourneur, F , an
R. Klausner, unpublished observations) show that an E
retained variant ofthe CD3-E chain in which the extracellulat
domain of CD3-E has been fused to the transmembrane and
cytoplasmic domains of the IL-2 receptor a chain, can co-
precipitate BiP in amounts equivalent to those observed for
the TCRa variants. In vitro treatment oflysates revealed that
BiP dissociated from this chimeric CD3-E chain when Caz+
is chelated, and thatthe degree ofdissociation is comparable
to that induced by ATP Furthermore, Caz+ can antagonize
the ability of ATP to release this CD3-E chimera from BiP
as demonstrated for TCR-a variants.
We have found that a correlate to these in vitro observa-
tions is that manipulation of Caz+ levels via the in vivo ap-
plication of A23187, can result in the secretion of soluble
TCR-a, and the surface expression of TCR-aopj, which are
otherwise ER retained. In the presence of A23187, BiP is not
secreted from COS or CHO cells as determined by pulse-
chase experiments and immunoblotting, nor does it appear
to redistribute out of the ER by immunofluorescence micros-
copy, indicating that dissociation from BiP occurs within the
ER system. The observation that specific inhibition of an ER
Caz+-translocating ATPase by the tumor promoter thapsigar-
gin has the same effect as A23187, supports the idea that the
maintenance of elevated lumenal Caz+ concentrations is
necessary for retaining TCRa, and TCR-aGp1 within the
ER. The recent cloning and characterization of the PMRI
gene in yeast lends further credence to this notion. Rudolph
et al. (1989) have shown that thePMRI gene productencodes
a Caz+-ATPase, and that pmrl mutants more efficiently se-
crete heterologous proteins which are by and large retained
in wild-type yeast cells. This defect has been genetically lo-
calized to the ER-Golgi transition within the secretory path-
way, the site where the release from ER retention would be
manifested .
To determine whether the effects seen with A23187 and Tg
reflect a decline in lumenal ER Caz+, or rather, an increase
of cytosolic levels coordinately induced by both of these re-
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agents, we utilized a membrane-permeable Cal+ chelator
BAPTAAM which is delivered tointracellular compartments
as well as to the cytosol. Although we cannot know the extent
to which Cat+ levels are decreased within the ER, we have
found that the presence of 100 nM extracellular BAPTAAM
is sufficient to release the lipid-linked TCR-a variant from
the ER and allow for transport through the Golgi as evi-
denced by the acquisition of carbohydrate modifications as-
sociated with the latter.
The molecular details of how Cal+ affects the interaction
of BiP and target proteins are not known. One formal possi-
bility is that Cat+ acts on a target protein bound to BiP by
inducing a conformational change that facilitates its release.
The alternative explanation, that Caz+ acts directly on BiP
itself, is supported by previous data indicating that BiP is a
Caz+-binding protein (Macer and Koch, 1988) and that Cat+
inhibits the ATPase activity of purified BiP (Kassenbrock
and Kelly, 1989). Clearly, a variety ofstimuli acting through,
for example, the IP3 receptor (Furuichi et al., 1989; Minery
et al ., 1989), GTP (Ghosh et al., 1989; Mullaney et al.,
1988) or an ER Cat+ATPase (Damiani et al., 1988; Lytton
and MacLennan, 1988), can function to regulate Caz+ lev-
els within the ER. In addition, the maintenance of Caz+
gradients throughout this complex and dynamic organelle
can itself be utilized to regulate the binding and release of
proteins from BiP . In so doing, an added levelof control can
be imposed upon the relationship between the synthesis,
maturation, andbinding to BiP by proteins at their site ofen-
trance (synthesis) and egress from the ER.
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